APOE-ε3 and APOE -219G haplotypes increase the risk for schizophrenia in sibling pairs

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 21, Issue 4, 2009, Pages 440-444

  Tovilla Zarate, Carlos ^a   Camarena Medellin, Beatriz ^b   Fresan, Ana ^b   Apiquian, Rogelio ^c   Dassori, Albana ^d   Rolando, Medina ^d   Escamilla, Michael ^d   Nicolini, Humberto ^a,c  

^a UNIVERSIDAD AUTÓNOMA DE LA CIUDAD DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^c Grupo de Estudios Médicos Y Familiares Carracci   (Mexico)

^d University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E3;

ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC LINKAGE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; SEX DIFFERENCE; SIBLING; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MEXICO; MULTICENTER STUDY; PATIENT SELECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALLELES; APOLIPOPROTEINS E; CHI-SQUARE DISTRIBUTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE (GENETICS); MALE; MEXICO; PATIENT SELECTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SIBLINGS;

EID: 85047684630     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2009.21.4.440     Document Type: Article

References (33)

1. Cannon TD, Kaprio J, Lonnqvist J, et al: The genetic epidemiology of schizophrenia in a Finnish twin cohort: a populationbased modeling study. Arch Gen Psychiatry 1998; 55:67-74
2. Siest G, Pillot T, Regis-Bailly A, et al: Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 1995; 41:1068-1086
3. Pitas RE, Boyles JK, Lee SH, et al: Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 1987; 917:148-161
4. Mahley RW: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240:622-630
5. Bosco P, Gueant-Rodriguez RM, Anello G, et al: Allele epsilon 4 of APOE is a stronger predictor of Alzheimer risk in Sicily than in continental south Italy. Neurosci Lett 2005; 388:168-172
6. Molero P, Ortuno F, Zalacain M, et al: Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment. Pharmacogenomics J 2007; 7:418-426
7. Pérez-Tur J, Campion D, Martínez M, et al: Evidence for apolipoprotein E epsilon 4 association in early-onset Alzheimer's patients with late-onset relatives. Am J Med Genet 1995; 60: 550-553
8. Packard CJ, Westendorp RG, Stott DJ, et al: Association between apolipoprotein E4 and cognitive decline in elderly adults. J Am Geriatr Soc 2007; 55:1777-1785
9. Arnold SE, Joo E, Martinoli MG, et al: Apolipoprotein E genotype in schizophrenia: frequency, age of onset, and neuropathologic features. Neuroreport 1997; 8:1523-1526
10. Harrington CR, Roth M, Xuereb JH, et al: Apolipoprotein E type epsilon 4 allele frequency is increased in patients with schizophrenia. Neurosci Lett 1995; 202:101-104
11. Tovilla-Zarate C, Camarena B, Apiquian R, et al: Association study and meta-analysis of the apolipoprotein gene and schizophrenia. Gac Med Mex 2008; 144:79-83
12. Sáiz PA, Morales B, G-Portilla MP, et al: Apolipoprotein E genotype and schizophrenia: further negative evidence. Acta Psychiatr Scand 2002; 105:71-75
13. Schurhoff F, Szoke A, Chevalier F, et al: Schizotypal dimensions: an intermediate phenotype associated with the COMT high activity allele. Am J Med Genet B Neuropsychiatr Genet 2007; 144B:64-68
14. Durany N, Riederer P, Cruz-Sánchez FF: Apolipoprotein E genotype in Spanish schizophrenic patients. Psychiatr Genet 2000; 10:73-77
15. Town T, Fallin D, Crawford F, et al: Lack of association between the apolipoprotein E epsilon 4 allele (APOEε4) and chronic schizophrenia. Am J Med Genet 1997; 74:451-452
16. Xu MQ, St Clair D, He L: Meta-analysis of association between APOE epsilon 4 allele and schizophrenia. Schizophr Res 2006; 84:228-235
17. Artiga MJ, Bullido MJ, Sastre I, et al: Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett 1998; 421:105-108
18. Escamilla MA, Ontiveros A, Nicolini H, et al: A genome-wide scan for schizophrenia and psychosis susceptibility loci in families of Mexican and Central American ancestry. Am J Med Genet B Neuropsychiatr Genet 2007; 144:193-199
19. Lahiri DK, Nurnberger JI Jr: A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19:5444
20. Wenham PR, Price WH, Blandell G: Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337:1158-1159
21. Chung RH, Morris RW, Zhang L, et al: X-APL: an improved family-based test of association in the presence of linkage for the X chromosome. Am J Hum Genet 2007; 80:59-68
22. Stephens M, Donnelly P: A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73:1162-1169
23. Illi A, Kampman O, Hanninen K, et al: Catechol-O-methyltransferase val108/158met genotype and response to antipsychotic medication in schizophrenia. Hum Psychopharmacol 2007; 22:211-215
24. Martorell L, Virgos C, Valero J, et al: Schizophrenic women with the APOE epsilon 4 allele have a worse prognosis than those without it. Mol Psychiatry 2001; 6:307-310
25. Alzheimer's Disease Collaborative Group: Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993; 342:737-738
26. Hardy J, Crook R, Perry R, et al: APOE genotype and down's syndrome. Lancet 1994; 343:979-980
27. Royston MC, Mann D, Pickering-Brown S, et al: Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's Syndrome from dementia. Neuroreport 1994; 5:2583-2585
28. Kimura T, Yokota S, Igata-Yi R, et al: Apolipoprotein E epsilon 2 allele and early onset schizophrenia. Neurosci Lett 1997; 231:53-55
29. Shinkai T, Ohmori O, Kojima H, et al: Apolipoprotein E regulatory region genotype in schizophrenia. Neurosci Lett 1998; 256:57-60
30. Ramos MC, Matías S, Artiga MJ, et al: Neuronal specific regulatory elements in apolipoprotein E gene proximal promoter. Neuroreport 2005; 16:1027-1030
31. Brecht WJ, Harris FM, Chang S, et al: Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci 2004; 24:2527-2534
32. Aoki K, Uchihara T, Sanjo N, et al: Increased expression of neuronal apolipoprotein E in human brain with cerebral infarction. Stroke 2003; 34:875-880
33. Campos-Sánchez R, Barrantes R, Silva S, et al: Genetic structure analysis of three Hispanic populations from Costa Rica, Mexico, and the southwestern United States using Y-chromosome STR markers and mtDNA sequences. Hum Biol 2006; 78:551-563